Dentsply Sirona (XRAY) Misses Q4 EPS by 3c; Offers 2022 Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q4 EPS of $0.76, $0.03 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.13 billion.

GUIDANCE:

Dentsply Sirona sees FY2022 EPS of $3.05-$3.25, versus the consensus of $3.19. Dentsply Sirona sees FY2022 revenue of $4.3-4.4 billion, versus the consensus of $4.48 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Investing.com’s stocks of the week